MétaCan
Menu
Back to cohort
Record W3033817849 · doi:10.1080/2162402x.2020.1774298

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

2020· review· en· W3033817849 on OpenAlexaff
Romain Daillère, Lisa Derosa, Mélodie Bonvalet, Nicola Segata, Bertrand Routy, Manuela Gariboldi, Eva Budínská, I. Jolanda M. de Vries, Alessio Naccarati, Valérie Zitvogel, Carlos Caldas, Lars Engstrand, Sibylle Loibl, Jacques Fieschi, Lucie Heinzerling, Guido Kroemer, Laurence Zitvogel

Bibliographic record

VenueOncoImmunology · 2020
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGut microbiota and health
Canadian institutionsCentre Hospitalier de l’Université de Montréal
FundersLabex Immuno-OncologyHigh-end Foreign Experts Recruitment Plan of ChinaEuropean Research Area Network on Cardiovascular DiseasesInstitut Universitaire de FranceCentre National de la Recherche ScientifiqueLigue Contre le CancerFondation pour la Recherche MédicaleInstitut National Du CancerInstitut National de la Santé et de la Recherche MédicaleAgence Nationale de la RechercheE-RareCancer Research UKAssociation pour la Recherche sur le CancerSeerave FoundationInstitut Gustave-RoussyFondation LeducqEuropean Commission
KeywordsGut floraClinical trialMedicineImmunotherapyCancerImmune checkpointCancer immunotherapyImmune systemMicrobiomeBlockadeImmunologyBioinformaticsInternal medicineBiologyReceptor

Abstract

fetched live from OpenAlex

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal intestinal microbiota supports therapeutic anticancer responses, while a dysbiotic microbiota that lacks immunostimulatory bacteria or contains overabundant immunosuppressive species causes treatment failure. These findings have led to the design of clinical trials that evaluate the capacity of modulation of the gut microbiota to synergize with treatment and hence limit tumor progression. Along the lines of this Trial Watch, we discuss the rationale for harnessing the gut microbiome in support of cancer therapy and the progress of recent clinical trials testing this new therapeutic paradigm in cancer patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.971
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0020.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.420
Teacher spread0.368 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations35
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueOncoImmunologySame topicGut microbiota and healthFrench-language works237,207